02420nam 2200637Ia 450 991080913420332120230617011601.00-309-18186-01-282-08332-597866120833270-309-54925-6(CKB)1000000000030468(SSID)ssj0000195765(PQKBManifestationID)11937294(PQKBTitleCode)TC0000195765(PQKBWorkID)10131781(PQKB)11327311(MiAaPQ)EBC3377934(Au-PeEL)EBL3377934(CaPaEBR)ebr10078700(CaONFJC)MIL208332(OCoLC)923274427(EXLCZ)99100000000003046820011123d2005 uy 0engurcn|||||||||txtccrMaking better drugs for children with cancer[electronic resource] /Peter C. Adamson, Susan L. Weiner, Joseph V. Simone, and Hellen Gelband, editorsWashington, D.C. National Academy of Sciences2005xiv, 42 pBibliographic Level Mode of Issuance: Monograph0-309-09608-1 Includes bibliographical references.Childhood cancers: Background -- Agents in use and in testing for children with cancer -- The existing capacity for developing new agents specifically for childhood cancers -- Putting the pieces together -- Delays in testing approved agents in children -- The need to prioritize agents for testing in children with cancer -- Testing and labeling of drugs for pediatric use.Antineoplastic agentsOncologyAntineoplastic agents.Oncology.618.92/994Adamson Peter C1594816Weiner Susan L1594817Simone Joseph V1594818Gelband Hellen1594819National Cancer Policy Board (U.S.).Committee on Shortening the Time Line for New Cancer Treatments.Institute of Medicine (U.S.)National Research Council (U.S.)National Academy of Sciences (U.S.)MiAaPQMiAaPQMiAaPQBOOK9910809134203321Making better drugs for children with cancer3915519UNINA